Chronic pain clinical trials in Brampton

Name: Chronic pain clinical trials in Brampton
Creator: Chronic Pain Canada

Trials

Recruiting or not yet

Trial sites

Trials with a site in Brampton

8 trials, recruiting first

		Phase
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain NCT07035093	Active, not recruiting	Phase 3	Eli Lilly and Company	2025-05-29
A Randomized, Controlled Study of Repeat Dose Sustained Release Lidocaine for Treatment of Chronic Scrotal Pain NCT05707208	Completed	Phase 2	Sustained Therapeutics Inc.	2023-03-21
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome NCT03500159	Terminated	Phase 2	Aquinox Pharmaceuticals (Canada) Inc.	2018-04-18
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome NCT02858453	Unknown status	Phase 3	Aquinox Pharmaceuticals (Canada) Inc.	2016-07
Evaluation of Galcanezumab in the Prevention of Chronic Migraine NCT02614261	Completed	Phase 3	Eli Lilly and Company	2015-11-30
A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain NCT00973141	Terminated	Phase 2	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	2009-09-16
A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Low Back Pain NCT00973024	Terminated	Phase 2	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	2009-09
An Open-label Extension Study With Flexible Dosing of Extended-release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic Pain NCT00487435	Completed	Phase 3	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	2007-06

Facilities listed in the registry

Site 1005 (2 trial sites)
For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician. (1 trial site)
Aggarwal and Associates Limited (1 trial site)
Jonathan Giddens Medicine Professional Corporation (1 trial site)

Facility names are as entered by study registrants. This is not a clinic directory.

Map

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.